Literature DB >> 8850388

Effects of Na(+)-H+ exchange blocker amiloride on left ventricular remodeling after anterior myocardial infarction in rats.

S Hasegawa1, M Nakano, Y Taniguchi, S Imai, K Murata, T Suzuki.   

Abstract

We investigated the effects of amiloride, a Na(+)-H+ exchange blocker, on ventricular remodeling in an infarcted rat model. In the amiloride group, the left descending coronary artery was ligated and rats were given amiloride (1 mg/kg/day, n = 11) in their drinking water for 4 weeks. In the control group, rats were given water for 4 weeks (n = 8) after myocardial infarction. The rats were killed on day 28. Both the ratio of heart weight to body weight and that of left ventricular weight to body weight were significantly less in the amiloride group (p < 0.05). The diameter of a myocardial fiber in the region adjacent to the operated area was significantly reduced in the amiloride group compared with the control group (p < 0.05). Left ventricular cavity dimension was significantly smaller in the amiloride group than that in control group (p < 0.05). Our findings suggest that amiloride prevents ventricular remodeling after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8850388     DOI: 10.1007/bf00879877

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  20 in total

1.  Contraction and intracellular Ca2+, Na+, and H+ during acidosis in rat ventricular myocytes.

Authors:  S M Harrison; J E Frampton; E McCall; M R Boyett; C H Orchard
Journal:  Am J Physiol       Date:  1992-02

2.  Load responsiveness of protein synthesis in adult mammalian myocardium: role of cardiac deformation linked to sodium influx.

Authors:  R L Kent; J K Hoober; G Cooper
Journal:  Circ Res       Date:  1989-01       Impact factor: 17.367

3.  Effects of amiloride on metabolism and contractility during reoxygenation in perfused rat hearts.

Authors:  R G Weiss; E G Lakatta; G Gerstenblith
Journal:  Circ Res       Date:  1990-04       Impact factor: 17.367

4.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

Authors:  M A Pfeffer; G A Lamas; D E Vaughan; A F Parisi; E Braunwald
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

5.  Protective effects of amiloride on the ischemic reperfused rat heart. Relation to mitochondrial function.

Authors:  J Duan; M Karmazyn
Journal:  Eur J Pharmacol       Date:  1992-01-14       Impact factor: 4.432

6.  Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange.

Authors:  M Tani; J R Neely
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

7.  Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.

Authors:  M A Pfeffer; J M Pfeffer; C Steinberg; P Finn
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

8.  Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function.

Authors:  P J Fletcher; J M Pfeffer; M A Pfeffer; E Braunwald
Journal:  Circ Res       Date:  1981-09       Impact factor: 17.367

9.  Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy.

Authors:  P Anversa; A V Loud; V Levicky; G Guideri
Journal:  Am J Physiol       Date:  1985-06

10.  Cellular basis of chronic ventricular remodeling after myocardial infarction in rats.

Authors:  G Olivetti; J M Capasso; L G Meggs; E H Sonnenblick; P Anversa
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

View more
  3 in total

Review 1.  The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure.

Authors:  M Karmazyn; J V Sostaric; X T Gan
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.

Authors:  Wolfgang J Linz; Andreas E Busch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-19       Impact factor: 3.000

Review 3.  Na+/H+ Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure.

Authors:  Huiting Xia; Aqeela Zahra; Meng Jia; Qun Wang; Yunfu Wang; Susan L Campbell; Jianping Wu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.